UB Paderborn / Katalog / Suche / in CDI

Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis

Journal of neuroimmunology, 2016-05, Vol.294, p.32-40

2016

Volltextzugriff (PDF)

Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.220-220

2017

Volltextzugriff (PDF)

Impact of Mesothelioma Histologic Subtype and Use of Cancer-Directed Surgery on Outcomes in the National Cancer Database

International journal of radiation oncology, biology, physics, 2022-02, Vol.112 (2), p.e5-e5

2022

Volltextzugriff (PDF)

Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation

Cancer gene therapy, 2012-03, Vol.19 (3), p.160-170

2012

Volltextzugriff (PDF)

Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice

Cancer gene therapy, 2009-04, Vol.16 (4), p.291-297

2009

Volltextzugriff (PDF)

Outcomes of Proton Beam Based SBRT in Medically Inoperable Stage I NSCLC

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S616-S617

2011

Volltextzugriff (PDF)

Abstract No. 79: Analysis of Local Tumor Progression Following Radiofrequency Ablation of Lung Tumors: 5 Year Experience

Journal of vascular and interventional radiology, 2009, Vol.20 (2), p.S31-S32

2009

Volltextzugriff (PDF)

P2.01-101 Multiple Chemotherapy-Based Combination Therapy Strategies for Advanced Lung Cancer Patients: A Systematic Review and Network Meta-Analysis

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S680-S680

2019

Volltextzugriff (PDF)

P1.03-32 Knockdown of CENPF Gene Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S431-S431

2019

Volltextzugriff (PDF)

OA20.04 Survival of Patients with Persistent N1 or N2 Disease After Induction Therapy for Stage IIIA-N2 Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S884-S884

2021

Volltextzugriff (PDF)

P68.02 Losartan Enhances Lung Squamous Cell Carcinoma’s Sensitivity to Cisplatin Treatment By Promoting Mesenchymal to Epithelial Transformation

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1198-S1198

2021

Volltextzugriff (PDF)

P06.03 The Role of Surgery for Stage 0 Adenocarcinoma in Situ of the Lung: A U.S. National Analysis

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S985-S986

2021

Volltextzugriff (PDF)

Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre

European journal of cardio-thoracic surgery, 2012-09, Vol.42 (3), p.430-437

2012

Volltextzugriff (PDF)

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice

Annals of oncology, 2011-12, Vol.22 (12), p.2616-2624

2011

Volltextzugriff (PDF)

Low Cardiopulmonary Toxicity With Use of IMRT When Delivering Postoperative Radiation Therapy (PORT) in Patients With NSCLC

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e442-e443

2021

Volltextzugriff (PDF)

Integration of EGFR Inhibition With Radiation-Based Multimodality Treatment in Stage III EGFR Mutant NSCLC

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e457-e457

2021

Volltextzugriff (PDF)

P1.12-17 Overall Survival and Recurrence After Surgical Resection of Pure and Mixed Large Cell Neuroendocrine Tumors

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S579-S580

2018

Volltextzugriff (PDF)

MA18.01 Non-Small Cell Lung Cancer Risk Assessment with Artificial Neural Networks

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S418-S418

2018

Volltextzugriff (PDF)

P3.16-01 A Multi-Omic Study Reveals BTG2 as a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S1003-S1003

2018

Volltextzugriff (PDF)

P1.03-42 Angiotensin System Inhibitors Improve Survival in Stage IIIA NSCLC and Show Anti-Tumor Effect in Combination with Chemotherapy in a Model of NSCLC

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S434-S435

2019

Volltextzugriff (PDF)

PS02.26 Multifocal Adenocarcinoma of the Lung: Factors Predictive for Local Therapy

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1574

2017

Volltextzugriff (PDF)

PS02.26 Multifocal Adenocarcinoma of the Lung: Factors Predictive for Local Therapy: Topic: Medical Oncology

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1574-S1574

2017

Volltextzugriff (PDF)

FP01.05 The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S188-S188

2021

Volltextzugriff (PDF)

A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S85-S86

2019

Volltextzugriff (PDF)

Use of protamine to augment adenovirus-mediated cancer gene therapy

Gene therapy, 1999-09, Vol.6 (9), p.1600-1610

1999

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis

Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy

Impact of Mesothelioma Histologic Subtype and Use of Cancer-Directed Surgery on Outcomes in the National Cancer Database

Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation

Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice

Outcomes of Proton Beam Based SBRT in Medically Inoperable Stage I NSCLC

Abstract No. 79: Analysis of Local Tumor Progression Following Radiofrequency Ablation of Lung Tumors: 5 Year Experience

P2.01-101 Multiple Chemotherapy-Based Combination Therapy Strategies for Advanced Lung Cancer Patients: A Systematic Review and Network Meta-Analysis

P1.03-32 Knockdown of CENPF Gene Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway

OA20.04 Survival of Patients with Persistent N1 or N2 Disease After Induction Therapy for Stage IIIA-N2 Non-Small-Cell Lung Cancer

P68.02 Losartan Enhances Lung Squamous Cell Carcinoma’s Sensitivity to Cisplatin Treatment By Promoting Mesenchymal to Epithelial Transformation

P06.03 The Role of Surgery for Stage 0 Adenocarcinoma in Situ of the Lung: A U.S. National Analysis

Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice

Low Cardiopulmonary Toxicity With Use of IMRT When Delivering Postoperative Radiation Therapy (PORT) in Patients With NSCLC

Integration of EGFR Inhibition With Radiation-Based Multimodality Treatment in Stage III EGFR Mutant NSCLC

P1.12-17 Overall Survival and Recurrence After Surgical Resection of Pure and Mixed Large Cell Neuroendocrine Tumors

MA18.01 Non-Small Cell Lung Cancer Risk Assessment with Artificial Neural Networks

P3.16-01 A Multi-Omic Study Reveals BTG2 as a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

P1.03-42 Angiotensin System Inhibitors Improve Survival in Stage IIIA NSCLC and Show Anti-Tumor Effect in Combination with Chemotherapy in a Model of NSCLC

PS02.26 Multifocal Adenocarcinoma of the Lung: Factors Predictive for Local Therapy

PS02.26 Multifocal Adenocarcinoma of the Lung: Factors Predictive for Local Therapy: Topic: Medical Oncology

FP01.05 The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC

A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA

Use of protamine to augment adenovirus-mediated cancer gene therapy

Suchergebnisse filtern